• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

奥密克戎变异株能否提供针对 COVID-19 的自然免疫力?

Can the SARS-CoV-2 Omicron Variant Confer Natural Immunity against COVID-19?

机构信息

Department of Biology, Faculty of Mathematics and Natural Sciences, Sam Ratulangi University, Manado 95115, North Sulawesi, Indonesia.

Department of Pharmacy, Faculty of Mathematics and Natural Sciences, Universitas Syiah Kuala, Kopelma Darussalam, Banda Aceh 23111, Aceh, Indonesia.

出版信息

Molecules. 2022 Mar 29;27(7):2221. doi: 10.3390/molecules27072221.

DOI:10.3390/molecules27072221
PMID:35408618
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9000495/
Abstract

The coronavirus disease 2019 (COVID-19) pandemic is still ongoing, with no signs of abatement in sight. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is the causative agent of this pandemic and has claimed over 5 million lives, is still mutating, resulting in numerous variants. One of the newest variants is Omicron, which shows an increase in its transmissibility, but also reportedly reduces hospitalization rates and shows milder symptoms, such as in those who have been vaccinated. As a result, many believe that Omicron provides a natural vaccination, which is the first step toward ending the COVID-19 pandemic. Based on published research and scientific evidence, we review and discuss how the end of this pandemic is predicted to occur as a result of Omicron variants being surpassed in the community. In light of the findings of our research, we believe that it is most likely true that the Omicron variant is a natural way of vaccinating the masses and slowing the spread of this deadly pandemic. While the mutation that causes the Omicron variant is encouraging, subsequent mutations do not guarantee that the disease it causes will be less severe. As the virus continues to evolve, humans must constantly adapt by increasing their immunity through vaccination.

摘要

2019 年冠状病毒病(COVID-19)大流行仍在继续,没有减弱的迹象。严重急性呼吸系统综合症冠状病毒 2(SARS-CoV-2)是导致这一大流行病的病原体,已导致超过 500 万人死亡,它仍在不断变异,产生了许多变体。最新的变体之一是奥密克戎,它的传染性增加了,但据报道住院率降低,症状也较轻,例如在已接种疫苗的人群中。因此,许多人认为奥密克戎提供了一种自然疫苗,这是结束 COVID-19 大流行的第一步。基于已发表的研究和科学证据,我们回顾和讨论了奥密克戎变体在社区中被超越如何导致预测大流行结束。鉴于我们研究的结果,我们相信奥密克戎变体很可能是一种为大众接种疫苗和减缓这种致命大流行病传播的自然方式。虽然导致奥密克戎变体的突变令人鼓舞,但随后的突变并不能保证它引起的疾病会不那么严重。随着病毒的不断进化,人类必须通过接种疫苗来不断增强免疫力,从而适应变化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc59/9000495/d47f15b55b7c/molecules-27-02221-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc59/9000495/138204d02546/molecules-27-02221-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc59/9000495/036d1ede843a/molecules-27-02221-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc59/9000495/3391a08e70ef/molecules-27-02221-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc59/9000495/d3ea869999cb/molecules-27-02221-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc59/9000495/d53d27165d3f/molecules-27-02221-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc59/9000495/d47f15b55b7c/molecules-27-02221-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc59/9000495/138204d02546/molecules-27-02221-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc59/9000495/036d1ede843a/molecules-27-02221-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc59/9000495/3391a08e70ef/molecules-27-02221-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc59/9000495/d3ea869999cb/molecules-27-02221-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc59/9000495/d53d27165d3f/molecules-27-02221-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc59/9000495/d47f15b55b7c/molecules-27-02221-g007.jpg

相似文献

1
Can the SARS-CoV-2 Omicron Variant Confer Natural Immunity against COVID-19?奥密克戎变异株能否提供针对 COVID-19 的自然免疫力?
Molecules. 2022 Mar 29;27(7):2221. doi: 10.3390/molecules27072221.
2
Global emerging Omicron variant of SARS-CoV-2: Impacts, challenges and strategies.全球新兴的 SARS-CoV-2 奥密克戎变异株:影响、挑战与策略。
J Infect Public Health. 2023 Jan;16(1):4-14. doi: 10.1016/j.jiph.2022.11.024. Epub 2022 Nov 19.
3
Unraveling the Dynamics of Omicron (BA.1, BA.2, and BA.5) Waves and Emergence of the Deltacton Variant: Genomic Epidemiology of the SARS-CoV-2 Epidemic in Cyprus (Oct 2021-Oct 2022).解析奥密克戎(BA.1、BA.2 和 BA.5)波动态及德尔塔克戎变异株出现:塞浦路斯 2021 年 10 月至 2022 年 10 月期间 SARS-CoV-2 流行的基因组流行病学。
Viruses. 2023 Sep 15;15(9):1933. doi: 10.3390/v15091933.
4
Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.疫苗对 Alpha、Delta 或奥密克戎变异株引起的 SARS-CoV-2 感染或 COVID-19 住院的有效性:一项全国性丹麦队列研究。
PLoS Med. 2022 Sep 1;19(9):e1003992. doi: 10.1371/journal.pmed.1003992. eCollection 2022 Sep.
5
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.新冠病毒-19(Sars-Cov-2)的英国变体不应造成疫苗问题。
J Biol Regul Homeost Agents. 2021 Jan-Feb;35(1):1-4. doi: 10.23812/21-3-E.
6
Potential immune evasion of the severe acute respiratory syndrome coronavirus 2 Omicron variants.严重急性呼吸综合征冠状病毒2奥密克戎变体潜在的免疫逃逸
Front Immunol. 2024 Feb 23;15:1339660. doi: 10.3389/fimmu.2024.1339660. eCollection 2024.
7
A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants.一种基于三聚体 RBD 的马赛克型 COVID-19 疫苗候选物可诱导针对奥密克戎和其他 SARS-CoV-2 变体的强大中和作用。
Elife. 2022 Aug 25;11:e78633. doi: 10.7554/eLife.78633.
8
Comparison of Omicron and Delta Variants of SARS-CoV-2: A Systematic Review of Current Evidence.奥密克戎和德尔塔变异株的比较:当前证据的系统评价。
Infect Disord Drug Targets. 2024;24(7):e050324227686. doi: 10.2174/0118715265279242240216114548.
9
Recent insights into SARS-CoV-2 omicron variant.对 SARS-CoV-2 奥密克戎变异株的最新认识。
Rev Med Virol. 2023 Jan;33(1):e2373. doi: 10.1002/rmv.2373. Epub 2022 Jun 4.
10
Favorable outcomes of COVID-19 in vaccinated hematopoietic stem cell transplant recipients: A single-center experience.接种疫苗的造血干细胞移植受者 COVID-19 结局良好:单中心经验。
Transpl Infect Dis. 2023 Jun;25(3):e14024. doi: 10.1111/tid.14024. Epub 2023 Feb 7.

引用本文的文献

1
Transmission Patterns of Co-Circulation of Omicron Sub-Lineages in Hong Kong SAR, China, a City with Rigorous Social Distancing Measures, in 2022.2022 年中国香港特别行政区,在严格社会隔离措施下,奥密克戎亚型共同传播模式。
Viruses. 2024 Jun 18;16(6):981. doi: 10.3390/v16060981.
2
Comparative Computational Analysis of Spike Protein Structural Stability in SARS-CoV-2 Omicron Subvariants.比较 SARS-CoV-2 奥密克戎亚变种刺突蛋白结构稳定性的计算分析。
Int J Mol Sci. 2023 Nov 8;24(22):16069. doi: 10.3390/ijms242216069.
3
American Singles' Attitudes Toward Future Romantic/Sexual Partners' COVID-19 Vaccination Status: Evidence for both Vigilance and Indifference in a National Sample.

本文引用的文献

1
Clinical outcomes associated with SARS-CoV-2 Omicron (B.1.1.529) variant and BA.1/BA.1.1 or BA.2 subvariant infection in Southern California.南加州与 SARS-CoV-2 奥密克戎(B.1.1.529)变异株以及 BA.1/BA.1.1 或 BA.2 亚变异株感染相关的临床结局。
Nat Med. 2022 Sep;28(9):1933-1943. doi: 10.1038/s41591-022-01887-z. Epub 2022 Jun 8.
2
Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination.奥密克戎变异株感染诱导的有限交叉免疫,未接种疫苗者尤其如此。
Nature. 2022 Jul;607(7918):351-355. doi: 10.1038/s41586-022-04865-0. Epub 2022 May 18.
3
Associations Between Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants and Risk of Coronavirus Disease 2019 (COVID-19) Hospitalization Among Confirmed Cases in Washington State: A Retrospective Cohort Study.
美国单身人士对未来浪漫/性伴侣新冠疫苗接种状况的态度:来自全国样本中警惕与冷漠并存的证据。
Sex Cult. 2023 May 18:1-24. doi: 10.1007/s12119-023-10097-9.
4
On the Implementation of the Artificial Neural Network Approach for Forecasting Different Healthcare Events.关于人工神经网络方法在预测不同医疗事件中的应用
Diagnostics (Basel). 2023 Mar 31;13(7):1310. doi: 10.3390/diagnostics13071310.
5
Mutation bias and the predictability of evolution.突变偏性与进化的可预测性。
Philos Trans R Soc Lond B Biol Sci. 2023 May 22;378(1877):20220055. doi: 10.1098/rstb.2022.0055. Epub 2023 Apr 3.
6
SARS-CoV-2-The Role of Natural Immunity: A Narrative Review.严重急性呼吸综合征冠状病毒2型——自然免疫的作用:一篇叙述性综述
J Clin Med. 2022 Oct 25;11(21):6272. doi: 10.3390/jcm11216272.
7
Clinical Progression and Outcome of Hospitalized Patients Infected with SARS-CoV-2 Omicron Variant in Shanghai, China.中国上海感染新型冠状病毒奥密克戎变异株住院患者的临床进展与结局
Vaccines (Basel). 2022 Aug 28;10(9):1409. doi: 10.3390/vaccines10091409.
8
Update on the omicron sub-variants BA.4 and BA.5.关于奥密克戎亚变体 BA.4 和 BA.5 的最新信息。
Rev Med Virol. 2023 Jan;33(1):e2391. doi: 10.1002/rmv.2391. Epub 2022 Aug 26.
9
Comparative overview of emerging RNA viruses: Epidemiology, pathogenesis, diagnosis and current treatment.新兴RNA病毒的比较概述:流行病学、发病机制、诊断及当前治疗方法
Ann Med Surg (Lond). 2022 Jul;79:103985. doi: 10.1016/j.amsu.2022.103985. Epub 2022 Jun 11.
10
Understanding the omicron variant (B.1.1.529) of SARS-CoV-2: Mutational impacts, concerns, and the possible solutions.了解严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的奥密克戎变种(B.1.1.529):突变影响、问题及可能的解决方案。
Ann Med Surg (Lond). 2022 Jun;78:103737. doi: 10.1016/j.amsu.2022.103737. Epub 2022 May 7.
严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2)变异株与华盛顿州确诊病例中 2019 年冠状病毒病(COVID-19)住院风险的相关性:一项回顾性队列研究。
Clin Infect Dis. 2022 Aug 24;75(1):e536-e544. doi: 10.1093/cid/ciac279.
4
Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2.未接种疫苗和接种疫苗的个体中感染原始、Delta 或奥密克戎 SARS-CoV-2 的传染性病毒载量。
Nat Med. 2022 Jul;28(7):1491-1500. doi: 10.1038/s41591-022-01816-0. Epub 2022 Apr 8.
5
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Naturally Acquired Immunity versus Vaccine-induced Immunity, Reinfections versus Breakthrough Infections: A Retrospective Cohort Study.严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)自然获得性免疫与疫苗诱导免疫、再感染与突破感染:一项回顾性队列研究。
Clin Infect Dis. 2022 Aug 24;75(1):e545-e551. doi: 10.1093/cid/ciac262.
6
Reduced pathogenicity of the SARS-CoV-2 omicron variant in hamsters.奥密克戎变异株在仓鼠中致病性降低。
Med. 2022 Apr 8;3(4):262-268.e4. doi: 10.1016/j.medj.2022.03.004. Epub 2022 Mar 17.
7
Massive third wave of COVID-19 outbreak in Bangladesh: a co-epidemic of dengue might worsen the situation.孟加拉国新冠疫情第三波大爆发:登革热的共同流行可能使情况恶化。
Future Virol. 2022 Jan. doi: 10.2217/fvl-2021-0182. Epub 2022 Mar 8.
8
Efficacy of Antiviral Agents against the SARS-CoV-2 Omicron Subvariant BA.2.抗病毒药物对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)奥密克戎亚型BA.2的疗效
N Engl J Med. 2022 Apr 14;386(15):1475-1477. doi: 10.1056/NEJMc2201933. Epub 2022 Mar 9.
9
Literature Review of Omicron: A Grim Reality Amidst COVID-19.奥密克戎的文献综述:新冠疫情下的严峻现实
Microorganisms. 2022 Feb 16;10(2):451. doi: 10.3390/microorganisms10020451.
10
Decoupling of omicron variant infections and severe COVID-19.奥密克戎变异株感染与重症新冠病毒肺炎的脱钩
Lancet. 2022 Mar 12;399(10329):1047-1048. doi: 10.1016/S0140-6736(22)00109-X. Epub 2022 Feb 18.